Omniab Inc (OABI)

$1.69 +0.03 (1.81%)
Market Cap 202.74M
Revenue (ttm) 26.39M
Net Income (ttm) -62.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -235.05%
Debt to Equity Ratio 0.00
Volume 355,200
Avg Vol 1,087,170
Day's Range N/A - N/A
Shares Out 122.14M
Stochastic %K 55%
Beta -0.03
Analysts Strong Sell
Price Target $8.25

Company Profile

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 250 7800
Address:
5980 Horton Street, Suite 600, Emeryville, United States
Winning_calls
Winning_calls Jun. 16 at 3:17 AM
$OABI pick me up @ $1.74
0 · Reply
willis2729
willis2729 Jun. 12 at 12:53 AM
$OABI In a 5/30/2025 SEC filing, Whitefort Capital Management, LP reported increasing their holdings from 3.91M shares to 7.3M shares. They now own 6% of the company. Strong hands are quietly accumulating shares that have risen 33% in the 8 trading days since 1.22 all-time low.
0 · Reply
tranq19
tranq19 Jun. 11 at 4:41 PM
$OABI anyone notice the 4M share buy??? More insider buying?? One of my 2 AI drug discovery stocks, joining the party with $ABCL
0 · Reply
tyogs
tyogs Jun. 6 at 5:43 PM
$OABI we need ti push through $1.50 and fly 💸 💰 🤑
0 · Reply
tyogs
tyogs Jun. 6 at 5:22 PM
$CHGG $OABI about to run come here and jump in before it takes off.
0 · Reply
tyogs
tyogs Jun. 6 at 3:48 PM
$BNAI $OABI no resistance until $1.70. Breaks that and can triple.
0 · Reply
tyogs
tyogs Jun. 6 at 3:39 PM
$GRRR $OABI is breaking off its lowest price range ever. $3 will be reached this year mark it!
0 · Reply
tyogs
tyogs Jun. 6 at 3:38 PM
$OABI is breaking out from all time lows.
0 · Reply
Suffix
Suffix May. 13 at 3:48 PM
$OABI starter avg $1.38, looking to trade not hang onto it till death
1 · Reply
fulmerjf
fulmerjf May. 13 at 3:27 PM
$OABI Couldn't resist, just picked some up.
0 · Reply
Latest News on OABI
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

May 13, 2025, 4:05 PM EDT - 6 weeks ago

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

May 10, 2025, 3:52 AM EDT - 6 weeks ago

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

May 8, 2025, 4:06 PM EDT - 7 weeks ago

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

OmniAb Introduces the xPloration® Partner Access Program

May 8, 2025, 4:05 PM EDT - 7 weeks ago

OmniAb Introduces the xPloration® Partner Access Program

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

May 5, 2025, 1:00 AM EDT - 7 weeks ago

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

OmniAb to Participate in Five Upcoming Investor Conferences

May 1, 2025, 8:00 AM EDT - 2 months ago

OmniAb to Participate in Five Upcoming Investor Conferences

OmniAb Announces Two New Appointments to its Board of Directors

Apr 21, 2025, 8:00 AM EDT - 2 months ago

OmniAb Announces Two New Appointments to its Board of Directors

OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 7:37 PM EDT - 3 months ago

OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript

OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Mar 18, 2025, 4:05 PM EDT - 3 months ago

OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

Feb 24, 2025, 8:00 AM EST - 4 months ago

OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

OmniAb to Participate in Two Investor Conferences in March

Feb 3, 2025, 4:57 PM EST - 5 months ago

OmniAb to Participate in Two Investor Conferences in March

Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm

Jan 31, 2025, 11:09 AM EST - 5 months ago

Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm

OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference

Dec 16, 2024, 4:15 PM EST - 6 months ago

OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference

OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 9:53 PM EST - 8 months ago

OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 12, 2024, 4:05 PM EST - 8 months ago

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights

OmniAb to Participate in Two Investor Conferences in November

Oct 30, 2024, 8:00 AM EDT - 8 months ago

OmniAb to Participate in Two Investor Conferences in November

OmniAb to Report Third Quarter 2024 Financial Results on November 12

Oct 22, 2024, 8:00 AM EDT - 8 months ago

OmniAb to Report Third Quarter 2024 Financial Results on November 12

OmniAb to Participate in Two Investor Conferences in September

Aug 26, 2024, 8:00 AM EDT - 10 months ago

OmniAb to Participate in Two Investor Conferences in September

OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 11:28 AM EDT - 11 months ago

OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript

OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights

Aug 8, 2024, 4:05 PM EDT - 11 months ago

OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights

Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging

Aug 6, 2024, 8:25 AM EDT - 11 months ago

Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging

FIP FTAI IMVT PRPL REAL RICK

OmniAb to Report Second Quarter 2024 Financial Results on August 8

Jul 25, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Report Second Quarter 2024 Financial Results on August 8

OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology

Jun 3, 2024, 4:05 PM EDT - 1 year ago

OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology

OmniAb to Participate in the Jefferies Global Healthcare Conference

May 20, 2024, 8:05 AM EDT - 1 year ago

OmniAb to Participate in the Jefferies Global Healthcare Conference

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit

May 15, 2024, 4:05 PM EDT - 1 year ago

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit

OmniAb, Inc. (OABI) Q1 2024 Earnings Call Transcript

May 10, 2024, 4:33 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q1 2024 Earnings Call Transcript

OmniAb Reports First Quarter 2024 Financial Results and Business Highlights

May 9, 2024, 4:05 PM EDT - 1 year ago

OmniAb Reports First Quarter 2024 Financial Results and Business Highlights

OmniAb to Participate in Five Investor Conferences in May

May 1, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Five Investor Conferences in May

OmniAb to Report First Quarter 2024 Financial Results on May 9

Apr 22, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Report First Quarter 2024 Financial Results on May 9

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics

Apr 15, 2024, 8:31 AM EDT - 1 year ago

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics

THAR

OmniAb, Inc. (OABI) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 7:38 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q4 2023 Earnings Call Transcript

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Mar 20, 2024, 4:05 PM EDT - 1 year ago

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

Feb 26, 2024, 8:00 AM EST - 1 year ago

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference

Dec 14, 2023, 4:30 PM EST - 1 year ago

OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference

OmniAb, Inc. (OABI) Research and Technology Virtual Event and Q3 2023 Earnings Call Transcript

Nov 14, 2023, 12:44 PM EST - 1 year ago

OmniAb, Inc. (OABI) Research and Technology Virtual Event and Q3 2023 Earnings Call Transcript

OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today's Research & Technology Virtual Event

Nov 9, 2023, 5:55 PM EST - 1 year ago

OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today's Research & Technology Virtual Event

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights

Nov 9, 2023, 8:00 AM EST - 1 year ago

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights

OmniAb Appoints Steve Love to its Board of Directors

Nov 1, 2023, 9:00 AM EDT - 1 year ago

OmniAb Appoints Steve Love to its Board of Directors

OmniAb Announces Agenda for its Research & Technology Virtual Event

Oct 31, 2023, 4:28 PM EDT - 1 year ago

OmniAb Announces Agenda for its Research & Technology Virtual Event

OmniAb to Hold Research & Technology Virtual Event on November 9

Oct 12, 2023, 8:00 AM EDT - 1 year ago

OmniAb to Hold Research & Technology Virtual Event on November 9

OmniAb: Hold For Growth

Sep 25, 2023, 9:22 PM EDT - 1 year ago

OmniAb: Hold For Growth

OmniAb, Inc. (OABI) Q2 2023 Earnings Call Transcript

Aug 12, 2023, 2:39 PM EDT - 2 years ago

OmniAb, Inc. (OABI) Q2 2023 Earnings Call Transcript

OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights

Aug 10, 2023, 4:05 PM EDT - 2 years ago

OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights

OmniAb Announces the Passing of Director Sunil Patel

Aug 7, 2023, 4:05 PM EDT - 2 years ago

OmniAb Announces the Passing of Director Sunil Patel

OmniAb to Report Second Quarter 2023 Financial Results on August 10

Jul 31, 2023, 8:00 AM EDT - 2 years ago

OmniAb to Report Second Quarter 2023 Financial Results on August 10

OmniAb: Plenty Of Potential

Jun 29, 2023, 1:31 PM EDT - 2 years ago

OmniAb: Plenty Of Potential

OmniAb Launches OmniDeep™ at the PEGS Boston Conference and Expo

May 17, 2023, 4:05 PM EDT - 2 years ago

OmniAb Launches OmniDeep™ at the PEGS Boston Conference and Expo

OmniAb: 6 Months In And Going Strong

May 15, 2023, 11:27 AM EDT - 2 years ago

OmniAb: 6 Months In And Going Strong

OmniAb, Inc. (OABI) Q1 2023 Earnings Call Transcript

May 12, 2023, 4:04 PM EDT - 2 years ago

OmniAb, Inc. (OABI) Q1 2023 Earnings Call Transcript

OmniAb Reports First Quarter 2023 Financial Results and Business Highlights

May 11, 2023, 7:00 AM EDT - 2 years ago

OmniAb Reports First Quarter 2023 Financial Results and Business Highlights

Winning_calls
Winning_calls Jun. 16 at 3:17 AM
$OABI pick me up @ $1.74
0 · Reply
willis2729
willis2729 Jun. 12 at 12:53 AM
$OABI In a 5/30/2025 SEC filing, Whitefort Capital Management, LP reported increasing their holdings from 3.91M shares to 7.3M shares. They now own 6% of the company. Strong hands are quietly accumulating shares that have risen 33% in the 8 trading days since 1.22 all-time low.
0 · Reply
tranq19
tranq19 Jun. 11 at 4:41 PM
$OABI anyone notice the 4M share buy??? More insider buying?? One of my 2 AI drug discovery stocks, joining the party with $ABCL
0 · Reply
tyogs
tyogs Jun. 6 at 5:43 PM
$OABI we need ti push through $1.50 and fly 💸 💰 🤑
0 · Reply
tyogs
tyogs Jun. 6 at 5:22 PM
$CHGG $OABI about to run come here and jump in before it takes off.
0 · Reply
tyogs
tyogs Jun. 6 at 3:48 PM
$BNAI $OABI no resistance until $1.70. Breaks that and can triple.
0 · Reply
tyogs
tyogs Jun. 6 at 3:39 PM
$GRRR $OABI is breaking off its lowest price range ever. $3 will be reached this year mark it!
0 · Reply
tyogs
tyogs Jun. 6 at 3:38 PM
$OABI is breaking out from all time lows.
0 · Reply
Suffix
Suffix May. 13 at 3:48 PM
$OABI starter avg $1.38, looking to trade not hang onto it till death
1 · Reply
fulmerjf
fulmerjf May. 13 at 3:27 PM
$OABI Couldn't resist, just picked some up.
0 · Reply
Armonica423
Armonica423 May. 10 at 6:49 PM
$OABI Big exposure for CYDY at 3 oncology conferences this coming week, do your dd research
0 · Reply
no_cry
no_cry May. 9 at 7:52 PM
$OABI fuck. I’m out
0 · Reply
tyogs
tyogs May. 8 at 8:43 PM
$OABI
0 · Reply
tyogs
tyogs May. 8 at 8:43 PM
$OABI bullish
0 · Reply
bearsoil
bearsoil May. 7 at 1:14 AM
$OABI Is this the bottom? revenue should ramp up in a yr weak biotech index
1 · Reply
Thestocktraderhubzee
Thestocktraderhubzee May. 5 at 10:04 AM
WATCHLIST MAY 05 2025 $OABI VERAXA Biotech Joins Forces with OmniAb to Develop Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors $AAPL Apple To Split iPhone Launches Starting 2026, Foldable Model May Debut With iPhone 18 Pro: Report $VIAV UBS Maintains Neutral on Viavi Solutions, Lowers Price Target to $11 $CSTL Castle Biosciences To Share New Data at DDW 2025 Highlighting TissueCypher Test's Ability To Identify Patients At Increased Risk For Developing Esophageal Cancer $NVO Novo Nordisk Announces The FDA Accepts Filing Application For Oral Semaglutide 25mg, Which If Approved, Would Be The First Oral GLP-1 Treatment For Obesity
0 · Reply
no_cry
no_cry May. 2 at 2:31 PM
$OABI dead
0 · Reply
bearsoil
bearsoil May. 1 at 12:29 AM
$OABI Look at the volume toward the close
0 · Reply
PenkeTrading
PenkeTrading Apr. 25 at 11:19 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of OmniAb Inc.. Is that bullish or bearish? $OABI #OmniAb #RsiOversold #NASDAQ
0 · Reply
Scooter0732
Scooter0732 Apr. 10 at 9:33 PM
$OABI https://www.fda.gov/news-events/press-announcements/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 30 at 10:56 AM
$OABI Digging OmniAb's antibody tech. Biotech play with strong partner network. Watching clinical program progression closely. Potential long-term value in discovery platform. insightful writeup: https://beyondspx.com/article/omniab-inc-nasdaq-oabi-pioneering-antibody-discovery-for-next-generation-therapeutics
0 · Reply
JarvisFlow
JarvisFlow Mar. 27 at 3:09 PM
RBC Capital updates rating for OmniAb ( $OABI ) to Outperform, target set at 7 → 4.
0 · Reply